Melanoma Research Institute
- Assets
- $58.0k
- Revenue
- $2.5k
- Investments
- $0.0
- Employees
- 0
- Location
- Tiburon, CA
- Founding
- 05/1992
- Data as of
- 12/2021
- EIN
- 68-0263472
Organization Overview
Melanoma Research Institute is located in Tiburon, CA. The organization was established in 1992. According to its NTEE Classification (H30) the organization is classified as: Cancer Research, under the broad grouping of Medical Research and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Melanoma Research Institute is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2021, Melanoma Research Institute generated $2.5k in total revenue. This represents a relatively dramatic decline in revenue. Over the past 7 years, the organization has seen revenues fall by an average of (46.8%) each year. All expenses for the organization totaled $770.0 during the year ending 12/2021. As we would expect to see with falling revenues, expenses have declined by (52.0%) per year over the past 7 years. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2021
Describe the Organization's Mission:
Part 3 - Line 1
CONDUCT RESEARCH AIMED AT DEVELOPING A BETTER THERAPY FOR PATIENTS WITH MALIGNANT MELANOMA (INCLUDES MAINTAINING A SOPHISTICATED PATIENT DATABASE DOCUMENTING THE NATURAL COURSE OF THE DISEASE AND THE EFFECTS OF THERAPEUTIC EFFORTS). EDUCATION OF THE PUBLIC, PATIENTS AND THE MEDICAL COMMUNITY ABOUT THE APPROPRIATE DIAGNOSIS AND TREATMENT OF MELANOMA.
Describe the Organization's Program Activity:
Part 3 - Line 4a
CONDUCT RESEARCH AIMED AT DEVELOPING A BETTER THERAPY FOR PATIENTS WITH MALIGNANT MELANOMA (INCLUDES MAINTAINING A SOPHISTICATED PATIENT DATABASE DOCUMENTING THE NATURAL COURSE OF THE DISEASE AND THE EFFECTS OF THERAPEUTIC EFFORTS). EDUCATION OF THE PUBLIC, PATIENTS AND THE MEDICAL COMMUNITY ABOUT THE APPROPRIATE DIAGNOSIS AND TREATMENT OF MELANOMA.
CONDUCT RESEARCH AIMED AT DEVELOPING A BETTER THERAPY FOR PATIENTS WITH MALIGNANT MELANOMA (INCLUDES MAINTAINING A SOPHISTICATED PATIENT DATABASE DOCUMENTING THE NATURAL COURSE OF THE DISEASE AND THE EFFECTS OF THERAPEUTIC EFFORTS). EDUCATION OF THE PUBLIC, PATIENTS AND THE MEDICAL COMMUNITY ABOUT THE APPROPRIATE DIAGNOSIS AND TREATMENT OF MELANOMA.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Dennis Fisher Secretary | Officer | 0 | $0 |
Lynn E Spitler MD President | Officer | 0.25 | $0 |
Melanie Adams CFO | Officer | 0 | $0 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $924 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $924 |
| Total Program Service Revenue | $0 |
| Investment income | $1,013 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $520 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $2,457 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $0 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $0 |
| Pension plan accruals and contributions | $0 |
| Other employee benefits | $0 |
| Payroll taxes | $0 |
| Fees for services: Management | $510 |
| Fees for services: Legal | $0 |
| Fees for services: Accounting | $240 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $0 |
| Advertising and promotion | $0 |
| Office expenses | $0 |
| Information technology | $0 |
| Royalties | $0 |
| Occupancy | $0 |
| Travel | $0 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $0 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $0 |
| Insurance | $0 |
| All other expenses | $20 |
| Total functional expenses | $770 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $5,792 |
| Savings and temporary cash investments | $52,246 |
| Pledges and grants receivable | $0 |
| Accounts receivable, net | $0 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $0 |
| Net Land, buildings, and equipment | $0 |
| Investments—publicly traded securities | $0 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $0 |
| Total assets | $58,038 |
| Accounts payable and accrued expenses | $0 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $0 |
| Total liabilities | $0 |
| Net assets without donor restrictions | $58,038 |
| Net assets with donor restrictions | $0 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $58,038 |
Grants Recieved
Over the last fiscal year, we have identified 2 grants that Melanoma Research Institute has recieved totaling $10.
| Awarding Organization | Amount |
|---|---|
Organization Name not Listed PURPOSE: SUPPORT CHARITABLE PURPOSE | | $5 |
Organization Name not Listed PURPOSE: SUPPORT CHARITABLE PURPOSE | | $5 |
Peer Organizations
| Organization Name | Assets | Revenue |
|---|---|---|
Translational Research In Oncology Us Inc Los Angeles, CA | $23,537,777 | $8,265,596 |
Pediatric Cancer Research Foundation Irvine, CA | $3,627,407 | $2,821,956 |
Nevada Cancer Research Foundation Inc Las Vegas, NV | $637,661 | $2,412,271 |
The International Genomics Consortium Phoenix, AZ | $13,871,737 | $3,350,681 |
Cancer Prevention Institute of California (CPIC) Foster City, CA | $0 | $44,595 |
Vanguard Cancer Foundation Long Beach, CA | $1,374,337 | $177,388 |
Prostate Cancer Research Institute Culver City, CA | $2,240,081 | $999,786 |
Keatons Child Cancer Alliance Roseville, CA | $375,909 | $787,785 |
Ethos Discovery San Diego, CA | $1,024,175 | $920,855 |
Sino-American Cancer Foundation Arcadia, CA | $0 | $1,131,529 |
Grassrootshealth Encinitas, CA | $16,808 | $760,113 |
Hers Breast Cancer Foundation Fremont, CA | $618,137 | $748,037 |